関連する実験動画
Updated: Feb 26, 2026

16:31
Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock
Published on: June 6, 2011
25.6K
出血性ショック後の血漿成分による内皮血栓炎症性機能不全
Kelly E Sanders1, Marissa D Pokharel2, Baron K Osborn1,2
1The University of Texas Health Science Center and the McGovern School of Medicine, Department of Surgery, Division of Acute Care Surgery, and the Center for Translational Injury Research, Houston, TX.
Shock (Augusta, Ga.)
|February 24, 2026
まとめ
外傷患者からの出血性ショック(HS)血漿は、炎症と凝固を増幅させ、血栓症のリスクを高めます。本研究は、内皮細胞、血栓炎症、および外傷後の合併症との重要な関連を明らかにします。
科学分野:
- 外傷と傷害研究
- 血管生物学
- 免疫学
背景:
- 外傷後の出血性ショック(HS)は、免疫活性化と過凝固状態を伴います。
- HS関連の血栓炎症における内皮細胞(EC)の役割は、完全には理解されていません。
- ECおよび血栓症傾向に対する外傷重症度の影響は、さらなる調査が必要です。
研究 の 目的:
- 外傷の重症度およびHSが内皮細胞を介した血栓炎症に及ぼす影響を調査すること。
- HS血漿が血栓症のリスクを高めるかどうかを判断すること。
- EC、血栓炎症、および外傷後の合併症との間のメカニズム的関連を解明すること。
主な方法:
- HSおよび外傷重症度別に層別化された外傷患者の血漿中の炎症性メディエーターを評価しました。
- ヒト肺微小血管内皮細胞(HLMVEC)を患者血漿に曝露し、トロンビン生成および遺伝子発現を測定しました。
- HS血漿注入およびIVC結紮によりマウスに血栓症を誘発し、組織学的分析を行いました。
主要な成果:
- 重症外傷およびHS患者由来の血漿は、炎症性メディエーターの上昇を示しました。
- 外傷血漿に曝露されたHLMVECは、特にHS患者において、トロンビン生成および血栓炎症遺伝子発現の増加を示しました。
- HS血漿を投与されたマウスは、好中球浸潤の増加とECトロンボモジュリンの減少を伴う、より大きな血栓を発生しました。
結論:
- HS血漿は、炎症性メディエーターの一部により、内皮の炎症と凝固を増強します。
- HS血漿は、invivo血栓症を促進します。
- 本研究は、EC、血栓炎症、および外傷後の合併症との間のメカニズム的関連を明らかにします。
関連する概念動画
Introduction to Hemostasis
15.2K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
15.2K
Formation of the Platelet Plug
10.0K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
10.0K
Extrinsic and Intrinsic Pathways of Hemostasis
14.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
14.0K
Clot Retraction and Fibrinolysis
9.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
9.5K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.1K
Blood Pressure Imbalances and Circulatory Shock
1.7K
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.7K

